Jeffrey P. Callen

Jeffrey P. Callen's AcademicInfluence.com Rankings

Jeffrey P. Callen

Philosophy

#3880

World Rank

#6193

Historical Rank

Logic

#1477

World Rank

#2241

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jeffrey P. Callen's Degrees

Doctorate Medicine University of Louisville

Why Is Jeffrey P. Callen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jeffrey P. Callen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. (2011) (3649)
Pyoderma Gangrenosum A Comparison of Typical and Atypical Forms with an Emphasis on Time to Remission. Case Review of 86 Patients from 2 Institutions (2000) (385)
A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. (1991) (310)
Nomenclature of Cutaneous Vasculitis (2018) (296)
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts (2018) (247)
Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients. (1982) (179)
Clinical features and treatment of peristomal pyoderma gangrenosum. (2000) (175)
Successful treatment of lentigo maligna and lentigo maligna melanoma with mohs' micrographic surgery aided by rush permanent sections (1994) (164)
Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. (1990) (154)
Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice. (1984) (153)
Cutaneous Manifestations of Internal Malignancy (2009) (148)
Development of sarcoidosis in cosmetic tattoos. (2005) (143)
Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. (1999) (136)
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. (1984) (135)
Dermatomyositis (1979) (130)
Vascular inflammation (vasculitis) in sweet syndrome: a clinicopathologic study of 28 biopsy specimens from 21 patients. (2002) (128)
Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. (1991) (127)
The value of malignancy evaluation in patients with dermatomyositis. (1982) (123)
AAD consensus statement on psoriasis therapies. (2003) (119)
Pyoderma gangrenosum: an update. (2007) (119)
A longitudinal study of human immunodeficiency virus transmission by heterosexual partners: de Vincenzi I for the European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994;331:341–346 (1995) (118)
Calciphylaxis with normal renal and parathyroid function: not as rare as previously believed. (2009) (116)
Amyopathic dermatomyositis (dermatomyositis siné myositis) (1992) (112)
Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. (2006) (112)
Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients. (1988) (111)
Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus (2004) (108)
Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. (1985) (106)
Dermatological Addendum to the 2012 International Chapel Hill Consensus Conference Nomenclature of Vasculitides (2017) (104)
Anti-C1q antibodies in systemic lupus erythematosus (2015) (103)
Cutaneous sarcoidal granulomas and the development of systemic sarcoidosis. (1981) (103)
Pyoderma gangrenosum and related disorders. (1989) (98)
Histopathologic comparison of the subsets of lupus erythematosus. (1990) (97)
Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. (2002) (96)
American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. (2004) (95)
Systematic reviews: grading recommendations and evidence quality. (2008) (94)
Pyoderma gangrenosum (1998) (89)
Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis (1996) (88)
Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases. (2001) (85)
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. (1998) (84)
Pemphigus associated diseases and induced pemphigus. (1983) (83)
Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. (1997) (82)
Associations of tumor necrosis factor alpha and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis. (2002) (81)
Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. (2006) (80)
Epidemiology of Systemic LE and Cutaneous LE (2015) (78)
Fluoroscopy-induced chronic radiation skin injury: a disease perhaps often overlooked. (2007) (77)
Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence. (1991) (75)
Cutaneous changes of dermatomyositis precede muscle weakness. (1989) (74)
Livedoid vasculopathy: what it is and how the patient should be evaluated and treated. (2006) (73)
Cutaneous lupus erythematosus: A personal approach to management (2006) (71)
Germline mutation in ATR in autosomal- dominant oropharyngeal cancer syndrome. (2012) (70)
Effects of acitretin on the liver. (1999) (70)
Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. (2006) (70)
Hydroxyurea-induced dermatomyositis-like eruption. (2003) (70)
Evidence supports blind screening for internal malignancy in dermatomyositis (2018) (68)
Peripheral ulcerative keratitis--an extracutaneous neutrophilic disorder: report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet's syndrome with an excellent response to cyclosporine therapy. (1999) (67)
Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed. (1994) (67)
Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. (2000) (65)
Internal disorders associated with bullous disease of the skin. A critical review. (1980) (65)
Relation between dermatomyositis and polymyositis and cancer (2001) (64)
Neutrophilic Dermatosis‐Associated Sterile Chronic Multifocal Osteomyelitis in Pediatric Patients: Case Report and Review (1999) (64)
Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. (2000) (63)
Bowen's and non-Bowen's squamous intraepidermal neoplasia of the skin. Relationship to internal malignancy. (1980) (62)
When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? (2002) (62)
Keratoacanthoma. A clinical study. (1984) (61)
Complications and adverse reactions in the use of newer biologic agents. (2007) (61)
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind, placebo-controlled trial (1995) (61)
Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients. (1985) (61)
Adalimumab effectively controlled recalcitrant generalized pustular psoriasis in an adolescent (2005) (60)
Relationship of cancer to inflammatory muscle diseases. Dermatomyositis, polymyositis, and inclusion body myositis. (1994) (59)
Guidelines of care for dermatomyositis. American Academy of Dermatology. (1996) (58)
Pyoderma gangrenosum (2020) (58)
Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations (2013) (56)
Disseminated Fusarium solani infection. (1995) (55)
Cutaneous leukocytoclastic vasculitis. Serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. (1990) (55)
Cutaneous Leukocytoclastic Vasculitis Serial Histopathologic Evaluation Demonstrates the Dynamic Nature of the Infiltrate (1990) (52)
Vesiculopustular eruption in a patient with ulcerative colitis. Pyoderma gangrenosum. (1985) (52)
Myositis and malignancy (1984) (51)
Methotrexate in psoriasis. A brief review of indications, usage, and complications of methotrexate therapy. (1980) (51)
Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. (2002) (51)
The presence of foreign bodies does not exclude the diagnosis of sarcoidosis. (2001) (51)
Pruritic urticarial papules and plaques of pregnancy (PUPPP). A clinicopathologic study. (1981) (50)
Nomenclature of systemic vasculitis (1995) (48)
Rheumatoid neutrophilic dermatitis in a woman with seronegative rheumatoid arthritis. (2001) (48)
Subacute cutaneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of forty-nine patients seen in a nonreferral setting. (1986) (47)
Cutaneous Manifestations of Dermatomyositis and Their Management (2010) (47)
Multicentric reticulohistiocytosis successfully treated with infliximab: an illustrative case and evaluation of cytokine expression supporting anti-tumor necrosis factor therapy. (2008) (47)
Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized. (2001) (47)
Cutaneous leukocytoclastic vasculitis: correlation of histopathological changes with clinical severity and course (1987) (46)
Azathioprine: a guide for the management of dermatology patients (2007) (46)
Update on the management of cutaneous lupus erythematosus (2004) (45)
Management of skin disease in patients with lupus erythematosus. (2002) (45)
Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate. (2004) (45)
Photoexacerbation of cutaneous lupus erythematosus due to ultraviolet A emissions from a photocopier. (1995) (45)
Dermatomyositis and malignancy. (1989) (45)
Tazarotene is an effective therapy for elastosis perforans serpiginosa. (2002) (45)
Sarcoidosis: a disorder with prominent cutaneous features and their interrelationship with systemic disease. (1980) (45)
Mannose Binding Lectin (MBL) Polymorphisms Associated with Low MBL Production in Patients with Dermatomyositis1 (2002) (44)
Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. (1990) (44)
Keratoacanthomas arising in hypertrophic lichen planus. A case report. (1981) (42)
Common pediatric and adolescent skin conditions. (2003) (42)
Dermatological Signs of Internal Disease (1994) (41)
Cutaneous Leukocytoclastic Vasculitis: Clinical Experience in 44 Patients (1987) (41)
Subcutaneous panniculitis-like T-cell lymphoma with vacuolar interface dermatitis resembling lupus erythematosus panniculitis. (2004) (41)
Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum. (1996) (41)
Generalized eruptive histiocytosis. (2004) (41)
Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum. (2004) (39)
Pyoderma gangrenosum Preceding the Diagnosis of Systemic Lupus erythematosus (2004) (39)
Oral lesions in systemic lupus erythematosus. Do ulcerative lesions represent a necrotizing vasculitis? (1992) (39)
Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM. (2012) (38)
Chlorambucil--an effective corticosteroid-sparing therapy for pyoderma gangrenosum. (1989) (38)
Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis (2006) (38)
Atypical melanocytic nevi. Clinical and histopathologic predictors of residual tumor at reexcision. (1992) (38)
Sweet's syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate of leukemic cells. (2001) (38)
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies (2021) (38)
Actinic keratoses. (1997) (38)
Hypersensitivity Reaction in a Child Due to Lamotrigine (1999) (37)
Paraneoplastic pemphigus in the absence of a known neoplasm. (1995) (37)
Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy. (2010) (37)
Recurrent pyoderma gangrenosum and agnogenic myeloid metaplasia. (1977) (36)
Neonatal lupus erythematosus occurring in one fraternal twin. Serologic and immunogenetic studies. (1985) (36)
Successful use of rituximab for cutaneous vasculitis. (2006) (36)
Mycophenolate mofetil as therapy for pyoderma gangrenosum. (2009) (36)
URINARY RETENTION ASSOCIATED WITH HERPES ZOSTER INFECTION (1993) (35)
Thalidomide in the treatment of recalcitrant Sweet's syndrome associated with myelodysplasia. (2005) (35)
Treatment of dermatomyositis with methotrexate and prednisone. (1979) (35)
Bullous pemphigoid and other disorders associated with autoimmune phenomena. (1978) (35)
Multicentric Reticulohistiocytosis in a 14‐Year‐Old Girl (2002) (35)
Bupropion‐induced subacute cutaneous lupus erythematosus (2005) (35)
Calcinosis cutis complicating adult-onset dermatomyositis. (2004) (35)
Hypercalcemia in association with cutaneous squamous cell carcinoma. Occurrence as a late complication of hidradenitis suppurativa. (1985) (35)
Neutrophilic dermatoses. (2002) (34)
A Case of Congenital Multiple Myofibromatosis Developing in an Infant (1999) (33)
Dermatitis herpetiformis: autoimmune disease associations. (1991) (33)
Management of "refractory" skin disease in patients with lupus erythematosus. (2005) (32)
Management of neutrophilic dermatoses (2012) (31)
Treatment of cutaneous lesions in patients with lupus erythematosus. (1994) (31)
Adult-onset recalcitrant eczema: a marker of noncutaneous lymphoma or leukemia. (2000) (31)
Comparative efficacy of 12% ammonium lactate lotion and 5% lactic acid lotion in the treatment of moderate to severe xerosis. (1989) (30)
Serum angiotensin I-converting enzyme level in patients with cutaneous sarcoidal granulomas. (1982) (30)
Clinical, serologic and immunogenetic studies in patients with chronic cutaneous (discoid) lupus erythematosus who have verrucous and/or hypertrophic skin lesions. (1988) (30)
Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea/scleroderma (2010) (30)
Intravenous immunoglobulin therapy for dystrophic calcinosis cutis: unreliable in our hands. (2009) (29)
Dermatology 2nd edition (2008) (29)
Bullous systemic lupus erythematosus: revised criteria for diagnosis (1995) (29)
Ability of primary care physicians to recognize physical findings associated with HIV infection (1996) (28)
Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis. (2002) (28)
Nivolumab-induced lichen planus pemphigoides. (2019) (28)
Serologic and clinical features of patients with discoid lupus erythematosus: relationship of antibodies to single-stranded deoxyribonucleic acid and of other antinuclear antibody subsets to clinical manifestations. (1985) (28)
Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection. (1998) (28)
Discoid lupus erythematosus--variants and clinical associations. (1985) (28)
Cutaneous leukocytoclastic vasculitis associated with active Wegener's granulomatosis. (1992) (27)
Development and validation of the Dermatomyositis Skin Severity Index (2007) (27)
Drug-Induced Linear IgA Bullous Dermatosis Mimicking Toxic Epidermal Necrolysis (2001) (27)
Bullous pemphigoid and rheumatoid arthritis. (1981) (27)
Sarcoidosis of the vulva: a rare cutaneous manifestation. (1998) (27)
Intralesional corticosteroids. (1981) (27)
Acute-onset, painful acral granuloma annulare: a report of 4 cases and a discussion of the clinical and histologic spectrum of the disease. (2006) (27)
Cutaneous mucinosis associated with lupus erythematosus. (1984) (26)
Clinically relevant information about cutaneous lupus erythematosus. (2009) (26)
Cutaneous vasculitis: what have we learned in the past 20 years? (1998) (26)
Glomeruloid hemangioma leading to a diagnosis of POEMS syndrome. (2006) (26)
Cutaneous vasculitis in systemic lupus erythematosus. A poor prognostic indicator. (1983) (26)
Cutaneous leukocytoclastic vasculitis complicating hairy cell leukemia (leukemic reticuloendotheliosis). (1986) (25)
Annular atrophic connective tissue panniculitis of the ankles. (1989) (25)
Leukemia cutis presenting as a scrotal ulcer. (1989) (24)
Ioversol-induced acute generalized exanthematous pustulosis: a case report. (2009) (24)
Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiation exposure. (2010) (24)
Neonatal Lupus Erythematosus Mimicking Langerhans Cell Histiocytosis (2003) (24)
Oculocutaneous manifestations observed in multisystem disorders. (1992) (24)
Bullous pemphigoid and Hashimoto's thyroiditis. (1981) (24)
Epidermolysis Bullosa Acquisita Responsive to Dapsone Therapy (2001) (24)
Prevention of osteoporosis associated with chronic glucocorticoid therapy. (2006) (23)
Silicone breast implants and the risk of connective tissue diseases and symptoms (1996) (23)
Human papillomavirus type 11 in multiple squamous cell carcinomas in a patient with subacute cutaneous lupus erythematosus. (1992) (23)
Golimumab-exacerbated subacute cutaneous lupus erythematosus. (2012) (23)
Clinical, serologic, and immunogenetic studies in patients with dermatomyositis. (1991) (23)
Recurrent Photosensitive Dermatitis Preceding Juvenile Dermatomyositis (1985) (23)
Hair loss in systemic disease. (1987) (23)
Cutaneous aspects of internal disease (1981) (23)
Developing classification criteria for skin‐predominant dermatomyositis: the Delphi process (2019) (22)
Calcifying lupus panniculitis in a patient with subacute cutaneous lupus erythematosus: response to diltiazem and chloroquine. (2001) (22)
Therapy of cutaneous lupus erythematosus (1982) (22)
Generalized acquired cutis laxa associated with multiple myeloma with biphenotypic IgG-λ and IgA-κ gammopathy following treatment of a nodal plasmacytoma. (2011) (22)
Bowen's disease and internal malignant disease. (1988) (22)
Effective treatment with α1-protease inhibitor of chronic cutaneous vasculitis associated with α1-antitrypsin deficiency (1995) (22)
Metastatic carcinoma of the breast. An unusual presentation mimicking cutaneous vasculitis (1987) (21)
Pyoderma gangrenosum treated successfully with potassium iodide. (1993) (21)
Tissue eosinophilia: not an indicator of drug-induced subacute cutaneous lupus erythematosus. (2012) (21)
Safety and efficacy of a broad-spectrum sunscreen in patients with discoid or subacute cutaneous lupus erythematosus. (1991) (21)
Sweet-like dermatosis in 2 patients with clinical features of dermatomyositis and underlying autoimmune disease. (2008) (21)
Severe cutaneous vasculitis complicating ulcerative colitis. (1979) (21)
Chlorambucil. An effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis. (1993) (20)
Relationship of cutaneous sarcoidosis to systemic disease. (1986) (20)
Oral metronidazole, an effective treatment for Sweet's syndrome in a patient with associated inflammatory bowel disease. (1994) (20)
In Patients with Systemic Lupus Erythematosus, Current Smokers Have More Active Skin Manifestations (2013) (20)
Mucocutaneous changes in patients with lupus erythematosus. The relationship of these lesions to systemic disease. (1988) (20)
Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency. (1987) (20)
Atypical fibroxanthoma with regional lymph node metastasis: report of a case and review of the literature. (2010) (20)
Dermatology, 3rd edition (2012) (20)
Necrotizing peripheral vasculitis/vasculopathy following the use of cocaine laced with levamisole. (2012) (20)
Leukocytoclastic vasculitis caused by drug additives. (1994) (20)
Incontinentia Pigmenti Presenting as Seizures (2002) (20)
Dapsone‐induced Peripheral Neuropathy (1986) (19)
Human histocompatibility antigen associations in patients with chronic cutaneous lupus erythematosus. (1985) (19)
African tick bite fever: a not-so-uncommon illness in international travelers. (2006) (19)
Collagen vascular diseases of childhood. (1991) (19)
Dermatomyositis and female malignancy (1986) (19)
Possible ultraviolet A-induced lentigines: a side effect of chronic tanning salon usage. (1989) (18)
Phenylephrine-induced microvascular occlusion syndrome in a patient with a heterozygous factor V Leiden mutation. (2007) (18)
Atypical herpes simplex infection masquerading as recalcitrant pemphigus vulgaris (2007) (18)
Treatment of severe cutaneous small-vessel vasculitis with mycophenolate mofetil. (2012) (18)
The red face: dermatomyositis. (1993) (18)
Sarcoidosis appearing initially as polymyositis. (1979) (17)
Collagen-vascular disease: An update. (1993) (17)
A cluster of Hodgkin's disease in a small community: evidence for environmental factors. (1978) (17)
Cutaneous vasculitis associated with pheochromocytoma. (1990) (17)
Etanercept Therapy for Toxic Epidermal Necrolysis (2009) (17)
Subacute cutaneous lupus erythematosus and porphyria cutanea tarda. Report of a case. (1981) (16)
Collagen vascular diseases. (2004) (16)
Oral and labial melanotic macules in a patient infected with human immunodeficiency virus. (1992) (16)
SKIN SIGNS OF INTERNAL MALIGNANCY (1987) (16)
Rothmund‐Thomson Syndrome: A Case Report (1989) (16)
Ophthalmologic Aspects of Chloroquine and Hydroxychloroquine Therapy (1983) (16)
The relationship of dermatomyositis/polymyositis to malignancy. (1991) (16)
A clinical approach to the vasculitis patient in the dermatologic office. (1999) (16)
Malignancy in polymyositis/dermatomyositis. (1988) (15)
Effective treatment with alpha 1-protease inhibitor of chronic cutaneous vasculitis associated with alpha 1-antitrypsin deficiency. (1995) (15)
Color Atlas of Dermatology (1993) (15)
Porphyria cutanea tarda and hepatitis C viral infection (1996) (15)
A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris. (1986) (15)
Dermatomyositis and multiple malignancies in a patient treated with methotrexate (1983) (15)
Development of complete heart block in an adult patient with Sjögren's syndrome and anti-Ro/SSA autoantibodies (1997) (14)
Paget disease in a man. (2008) (14)
Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients. (2010) (14)
Protection of patients' right to privacy in clinical photographs, video, and detailed case descriptions. (2014) (14)
CUTANEOUS ANGIITIS (VASCULITIS) (1978) (14)
Atypical presentation of herpes simplex virus in a patient with chronic lymphocytic leukemia. (1999) (14)
Treatment of cutaneous lesions in patients with lupus erythematosus. (1990) (14)
The use of pulse methylprednisolone and chlorambucil in the treatment of Sweet's syndrome. (1989) (14)
Randomized trial of oral aspirin for chronic venous leg ulcers: Layton AM, Ibbotson SH, Davies JA, et al. Lancet 1994;344:164-5 (1995) (14)
Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy". (2013) (13)
Porphyria cutanea tarda as a cause of bullous dermatosis of hemodialysis. A case report and review of the literature. (1981) (13)
Granulomatous hepatitis associated with salicylazosulfapyridine therapy. (1978) (13)
Chronic, recurrent small-vessel cutaneous vasculitis. (1982) (13)
Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology. (1996) (13)
Acute febrile neutrophilic dermatosis. Sweet's syndrome. (1981) (13)
Self-Healing Congenital Langerhans Cell Histiocytosis Presenting as Neonatal Papulovesicular Eruption (2001) (13)
New validated diagnostic criteria for pyoderma gangrenosum. (2019) (13)
Nonhealing ulcer secondary to factor V Leiden mutation and cryofibrinogenemia. (2004) (13)
Guidelines of care for cutaneous adverse drug reactions. American Academy of Dermatology. (1996) (13)
New psoriasis treatments based upon a deeper understanding of the pathogenesis of psoriasis vulgaris and psoriatic arthritis: a personal appraisal of their use in practice. (2003) (12)
Pyoderma gangrenosum: an expert commentary (2006) (12)
The use of B vitamins for cutaneous ulcerations mimicking pyoderma gangrenosum in patients with MTHFR polymorphism. (2011) (12)
Cutaneous Mast Cell Quantity in Pruritic and Nonpruritic Hemodialysis Patients (1988) (12)
Discoid Lupus Erythematosus in a Patient with Vitiligo and Autoimmune Thyroiditis (1984) (12)
Aggressive behavior of squamous cell carcinoma in a patient with preceding lymphocytic lymphoma. (1981) (12)
Necrotizing Vasculitis (Angiitis) with Granulomatosis (1984) (11)
Epidermolysis Bullosa Acquisita Responsive to Dapsone Therapy (2001) (11)
How frequently are drugs associated with the development or exacerbation of subacute cutaneous lupus? (2003) (11)
Severe sun sensitivity and the presence of antinuclear antibodies in patients with polymorphous light eruption-like lesions. (1992) (11)
Etiologic agents in the development of skin cancer. (1980) (11)
Urticaria, angioedema, and rheumatologic disease. (1996) (10)
Management of skin disease in lupus. (1997) (10)
Symmetric polyarthritis with livedo reticularis: a newly recognized manifestation of hepatitis C virus infection. (1997) (10)
Leukaemia cutis in a patient treated for breast cancer (2009) (10)
Thalidomide for Type 1 Cryoglobulinemic Vasculopathy (2006) (10)
Nifedipine in Scleroderma Ulcerations (1984) (10)
Dystrophic calcinosis cutis in pseudoxanthoma elasticum. (2008) (10)
Comparison of safety and efficacy of fluticasone propionate cream, 0.05%, and betamethasone valerate cream, 0.1%, in the treatment of moderate-to-severe psoriasis. (1996) (10)
Therapy‐related leukaemia cutis: A review (2008) (10)
Sarcoidal anemia and leukopenia treated with methotrexate and mycophenolate mofetil. (2009) (10)
Cutaneous bullae following acute steroid withdrawal in systemic lupus erythematosus (1981) (10)
Necrosing livedo reticularis in a patient with recurrent pulmonary hemorrhage. (1997) (10)
Dermatomyositis: diagnosis, evaluation and management. (2002) (10)
Cutaneous leukocytoclastic vasculitis with hyperglobulinemia and splenomegaly. A variant of hyperglobulinemic purpura of Waldenström. (1984) (10)
Intralesional triamcinolone is effective for discoid lupus erythematosus of the palms and soles. (1985) (10)
Immunomodulatory treatment for dermatomyositis (2008) (10)
The tetracycline-oral contraceptive controversy. (1982) (9)
Urticaria and polymyositis. (1978) (9)
Acute Febrile Mucocutaneous Lymph Node (Kawasaki) Syndrome (1987) (9)
Prevalence of Cutaneous Findings in Hospitalized Pediatric Patients (1997) (9)
Dermatological Signs of Systemic Disease (2016) (9)
Dermatitis Herpetiformis and Thyrotoxicosis (1979) (9)
Calciphylaxis With Normal Renal and Parathyroid Function (2013) (9)
Collagen vascular diseases. (1998) (9)
Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus (1995) (9)
Cutaneous non-X histiocytosis: clinical and histologic features and response to dermabrasion. (1985) (9)
Cutaneous vasculitis: Relationship to systemic disease and therapy (1993) (9)
Verrucous carcinoma in a reanl transplant patient after long-term immunosuppression. (1980) (9)
Position paper on family or personal leave, including pregnancy, during residency. (2001) (8)
Disseminated Kaposi's sarcoma in a patient with acquired ichthyosis (1984) (8)
Is subacute cutaneous lupus erythematosus a subset of systemic lupus erythematosus or a distinct entity? (2001) (8)
Antimalarial Agents (2020) (8)
Sweet's syndrome in a patient with enterococcal subacute bacterial endocarditis. (2004) (8)
Hydroxyurea-induced leg ulceration in a patient with a homozygous MTHFR polymorphism misdiagnosed as pyoderma gangrenosum. (2014) (8)
Azathioprine: effective steroid-sparing therapy for generalized lichen planus. (1992) (8)
Bilateral ulcers in a patient with a hereditary bullous dermatosis. Squamous cell carcinoma (SCC) arising in recessive dystrophic bullous dermatosis. (1987) (8)
Cutaneous lupus erythematosus: Reflecting on practice-changing observations over the past 50 years. (2018) (8)
Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris. (1999) (8)
FOLLICULAR MUCINOSIS ASSOCIATED WITH PREGNANCY (1992) (8)
The spectrum of Reiter's disease. (1979) (8)
Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus. (1999) (8)
Rhinophymalike Swelling in an 86-Year-Old Woman—Quiz Case (2004) (8)
Should dermatologic surgery training in residency be expanded? (2001) (8)
The Best of the Best: A New Section Led by Henry W. Lim, MD (2010) (8)
Cutaneous leukocytoclastic vasculitis in a patient with an adenocarcinoma of the colon. (1987) (8)
Statement on actinic keratoses (2000) (8)
Interstitial Granulomatous Dermatitis as the Initial Manifestation of Myeloma. (2015) (8)
Cutaneous dermatomyositis in the era of biologicals (2015) (8)
Association of inflammatory eye disease with granuloma annulare? (2008) (8)
Dermatomyositis occurring during psoralen A (PUVA) therapy. (1994) (7)
Kopf AW, Bart RS, Hennessey P. Congenital nevocytic nevi and malignant melanomas (2004) (7)
Recalcitrant tinea corporis as the presenting manifestation of patch-stage mycosis fungoides. (2003) (7)
Mycophenolate mofetil treatment of a patient with hyperglobulinemic purpura. (2004) (7)
Lupus erythematosus hypertrophicus. Two case reports and a review of the literature. (1981) (7)
Pregnancy's effects on the skin. Common and uncommon changes. (1984) (7)
Immunoperoxidase Technique on Paraffin Sections Fails to Demonstrate Immunoglobulin Deposition in Cutaneous Lesions from Patients with Dermatomyositis (1988) (7)
Type II mixed cryoglobulinemia following influenza and pneumococcal vaccine administration (2019) (7)
Myopathy induced by antimalarial agents: the relevance of screening muscle enzyme levels. (2009) (7)
Pustular eruptions in systemic disease. (2000) (7)
Systemic complications of commonly used dermatologic drugs. (1978) (7)
Widespread cutaneous necrosis as the initial manifestation of the antiphospholipid antibody syndrome. (1995) (7)
Low-dose methotrexate as an adjunctive therapy with surgery for ectropion complicating dermatomyositis. (1996) (7)
Metastatic Colonic Adenocarcinoma to the Glans Penis (1982) (7)
Early-onset obesity and risk for psoriatic arthritis. (2010) (6)
Facial dermatitis from a neoprene rubber mask (1988) (6)
Dermatologic comorbidities of diabetes mellitus and related issues. (2009) (6)
The use of cyclosporine for Stevens-Johnson syndrome-toxic epidermal necrolysis spectrum at the University of Louisville: A case series and literature review. (2018) (6)
Dermatomyositis: current and future treatments (2009) (6)
CUTANEOUS VASCULITIS AND ITS RELATIONSHIP TO SYSTEMIC DISEASE (1987) (6)
Cutaneous vasculitis as the initial manifestation in acute myelomonocytic leukemia (1995) (6)
Granulomatous cutaneous rheumatoid vasculitis. (1988) (6)
No walk in the park. (2005) (6)
Cutaneous vasculitis and its relationship to systemic disease. (1981) (6)
Guidelines of care for scleroderma and sclerodermoid disorders. American Academy of Dermatology. (1996) (6)
New and emerging therapies for collagen-vascular diseases. (2000) (6)
Giant Porokeratosis With Malignant Transformation to Squamous Cell Carcinoma. (2017) (6)
Biotechnology succeeds in revolutionizing medical science. (2005) (5)
Rhinophyma-like swelling of the nose due to squamous cell carcinoma of the lung metastatic to the nasal tip: a case report (1995) (5)
Rosai-Dorfman disease with a concurrent mantle cell lymphoma (2018) (5)
Newly recognized cutaneous drug eruptions. (2007) (5)
Unilateral emboli in a patient with thrombotic thrombocytopenic purpura. (1993) (5)
Rhinophymalike swelling in an 86-year-old woman. Primary cutaneous B-cell lymphoma of the nose. (2004) (5)
Supplementing Dermatology Physician Resident Education in Vasculitis and Autoimmune Connective Tissue Disease: A Prospective Study of an Online Curriculum (2019) (5)
Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders. (2001) (5)
Is antinuclear and other antibody testing useful diagnostically in patients with photosensitivity (1991) (5)
Systemic blastomycosis treated with ketoconazole. (1984) (5)
Lupus erythematosus. Historical perspectives. (1985) (5)
Raynaud Phenomenon in Children (2003) (5)
Necrotizing Neutrophilic Dermatitis, an Often-Misdiagnosed Entity With Potentially Severe Consequences. (2019) (4)
CHOLECYSTOCUTANEOUS FISTULA (1979) (4)
Eruptive Keratoacanthomas Associated With Leflunomide. (2016) (4)
Off-Label Use of Azathioprine in Dermatology (2011) (4)
Practice Gaps. Optimizing antimalarial therapy for cutaneous lupus erythematosus: comment on "Response to antimalarial agents in cutaneous lupus erythematosus". (2011) (4)
Overlapping cutaneous disorders related to dermatitis herpetiformis. (1991) (4)
Methotrexate-Associated B-Cell Lymphoproliferative Disease in a Patient With Cutaneous T-Cell Lymphoma. (2018) (4)
Thermonuclear Tokamak Panel Report (2000) (4)
Keratotic spines in a patient with pruritic and dyskeratotic dermatosis: A new clinical finding (2020) (4)
Anti-TNF–Induced Psoriasis in Patients with Inflammatory Bowel Disease (2012) (4)
Dermatomyositis and malignancy. (1976) (4)
Eradication of hepatitis C virus RNA after alpha-interferon therapy (1995) (4)
Drug-induced subacute cutaneous lupus erythematosus associated with abatacept (2020) (4)
Clinical trial registration: a step forward in providing transparency for the positive and negative results of clinical trials. (2005) (4)
Consider drugs as a cause or an exacerbating factor in patients diagnosed with subacute cutaneous lupus erythematosus! (2012) (4)
The importance of a name. (2013) (4)
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis: Roujean J-C, Kelly JP, Naldi L, et al. N Engl J Med 1995;333:1600–1607 (1996) (4)
Cutaneous incisional endometriosis. (2009) (3)
Subsets of lupus erythematosus: clinical, serologic, and immunologic considerations. (1986) (3)
Panniculitis associated with hepatitis. (1983) (3)
162 – Cutaneous vasculitis and panniculitis (2015) (3)
Painful acral purpuric nodules. (1994) (3)
Generalized linear IgA dermatosis with palmar involvement. (2015) (3)
A novel epitope within the BP180 NC16A domain is targeted by autoantibodies in lichen planus pemphigoides (1998) (3)
Disseminated molluscum contagiosum associated with immunomodulatory therapy (2020) (3)
Facial papules and nodules, thyroid goiter, and acral keratoses. Cowden's disease. (1987) (3)
Misdiagnosed Periocular Pyoderma Gangrenosum Requiring Ectropion Repair With Development of Second Lesion of Pyoderma Gangrenosum at Graft Site. (2016) (3)
Thwarting a killer. (2006) (3)
Publishing Online Ahead of Print (2010) (3)
Cutaneous Lymphoproliferative Disorder Complicating Infectious Mononucleosis in an Immunosuppressed Patient (2011) (3)
Koebner Phenomenon in Juvenile Dermatomyositis (2018) (3)
Assurance of protection of human subjects' safety and privacy. (2009) (3)
Interferon and hepatitis C: Terrault N, Wright T. N Engl J Med 1995;332: 1509–1511 [Editorial] (1995) (3)
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas (1995) (3)
Painful acral purpura. (1998) (3)
Pembrolizumab-induced bullous pemphigoid (2018) (3)
Cutaneous manifestations of selected rheumatologic diseases. (1996) (3)
Color Atlas of Dermatology. 2nd Edition (1999) (3)
The cutting edge: Thalidomide for type 1 cryoglobulinemic vasculopathy. (2006) (3)
Management of pyoderma gangrenosum (2002) (2)
Sclerodermatomyositis and adenocarcinoma of the colon. (1985) (2)
Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies (2021) (2)
Hypertrophic lichen planus secondary to nivolumab therapy (2018) (2)
Introducing the practice gap commentary section. (2010) (2)
Cutaneous T-Cell Lymphoma Misdiagnosed as Lipodermatosclerosis. (2016) (2)
Association of Treatment With Secukinumab With Exacerbation of Dermatomyositis in a Patient With Psoriasis. (2022) (2)
IgA pemphigus and linear IgA bullous dermatosis in a patient with ulcerative colitis (2020) (2)
Cutaneous Lupus Erythematosus of the Vulvar Skin. (2021) (2)
Liver Biopsies in Patients on Methotrexate for the Treatment of Psoriasis (1980) (2)
Mucous membranes in systemic disease. (1987) (2)
www.archdermatol.com communicates with the international dermatology community. (2005) (2)
Miscellaneous Disorders With Prominent Features Involving the Skin and the Joints (2009) (2)
Systemic Therapy for Cutaneous Disease (2009) (2)
Cutaneous Vasculitis in Patients with Primary Sjögren Syndrome (2004) (2)
Management of Cutaneous Lupus Erythematosus (2005) (2)
Immunologic Testing in the Dermatologic Patient (1987) (2)
Panel discussion and concluding remarks (2000) (2)
Cutaneous Findings in Patients with Chronic Lymphocytic Leukemia (2004) (2)
Use of antibiotics and risk of cancer. (2004) (2)
Immunosuppressive and Cytotoxic Drugs in Dermatology: A Practical Overview and Personal Perspective (1996) (2)
Medical dermatology is alive and well. (2005) (2)
Photodermatitis in a 6-year-old child. (1993) (2)
Stevens-Johnson Syndrome Associated with (2015) (2)
Author Attribution, Financial Disclosure, and Financial Relationships (2006) (2)
Dermatologic Effects of Cancer (1989) (2)
Hepatitis C Viral Infection and Porphyria Cutanea Tarda. (2017) (2)
A Clinical Atlas of 101 Common Skin Diseases With Histopathologic Correlation (2001) (2)
Tumid Lupus Erythematosus: A Form of Lupus Erythematosus—Reply (2010) (2)
Are Major Adverse Cardiovascular Events Associated with Anti–IL-12/23 Therapies? (2011) (2)
Nonmelanoma skin cancer associated with use of a tanning bed (1996) (2)
Cutaneous sclerosis: a previously undescribed manifestation of sclerosing mesenteritis. (2010) (2)
Metastatic carcinoma of the cervix in a patient with dermatomyositis. (1989) (2)
Improvement of severe psoriatic nail involvement with alefacept therapy (2004) (2)
Immunosuppressive and cytotoxic drugs: uses in the dermatologic patient. (1990) (2)
DERMATOMYOSITIS AND POLYMYOSITIS UPDATE ON CURRENT CONTROVERSIES (1987) (2)
Mid-dermal elastolysis in a patient undergoing chronic hemodialysis. (2009) (2)
Poikilodermatous plaques on the torso of a young man. Granulomatous slack skin syndrome. (1997) (2)
Myositis and malignancy. (1989) (2)
Cutaneous manifestations of bacterial infections. (1989) (1)
Periodic synopsis on collagen vascular disease (1985) (1)
LEOPARD Syndrome in a Patient with Morphea and Acro-Osteolysis (1998) (1)
I need contact’ — rock’n’roll and ritual Peter Gabriel: Security tour, 1982–83 (2017) (1)
Mycobacterium mucogenicum infection following dacryocystorhinostomy and Crawford tube placement. (2014) (1)
Approach to and Management of the Neutrophilic Dermatoses (2016) (1)
27154 Lichen planus pemphigoides in a patient recently started on lisinopril (2021) (1)
Sleep Tight, and Don't Let the Bedbugs Bite!! (2012) (1)
Sarcoidosis: A Multisystem Disorder with Prominent Ocular and Cutaneous Involvement (1985) (1)
The Janus Kinase Inhibitor Ruxolitinib Might Be Effective for Dermatomyositis (2015) (1)
Pyoderma gangrenosum in association with psoriatic arthritis (1995) (1)
Interventions for morphea (2003) (1)
Frequency of Recurrence of Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis (2014) (1)
Pyoderma Gangrenosum After Breast Surgery (2014) (1)
An approach to the patient with a recalcitrant dermatosis. (2005) (1)
Effects of Finasteride on Prostate-Specific Antigen (2006) (1)
Hyperbaric Oxygen — An Effective Therapy for Livedoid Vasculopathy (2006) (1)
Rituximab Is Effective for ANCA-Associated Vasculitis (2009) (1)
New patterns of cutaneous drug eruptions. (2020) (1)
Pediatric Discoid Lupus Erythematosus (2015) (1)
Mycophenolate Mofetil for Childhood Atopic Dermatitis (2007) (1)
Pyoderma gangrenosum and related disorders. (1989) (1)
Our Thanks to the ARCHIVES Peer Reviewers (2006) (1)
Should Nephrogenic Fibrosing Dermopathy Have a New Name (2004) (1)
Mixed Connective Tissue Disease: An Overview (1982) (1)
Cutaneous leishmaniasis: a diagnostic challenge1 (2004) (1)
Treatment of Vulvar Lichen Sclerosus (2004) (1)
Anti-Epiligrin Cicatricial Pemphigoid -- New Findings (2003) (1)
Scurvy masquerading as cellulitis1 (2004) (1)
Esophageal Involvement Is Not Seen in Patients with Morphea (Localized Scleroderma) (2015) (1)
Tissue Eosinophilia as an Indicator of Drug‐Induced Leukocytoclastic Vasculitis: A Clinicopathologic Investigation (2008) (1)
Medical Applications of Biotechnology: Call for Papers (2004) (1)
DIAGNOSIS OF SUPERIOR-VENE-CAVA OBSTRUCTION (1974) (1)
LB1108 Association of aplastic anemia with isotretinoin: Is it more common than we think? (2019) (1)
Should PET Scanning Replace Current Malignancy Screening Methods in Dermatomyositis (2010) (1)
Rivaroxaban: Another Treatment for Livedoid Vasculopathy? (2012) (1)
Cutaneous Drug Eruptions (2009) (1)
Remember to Consider Dermatophyte Infection When Dealing With Recalcitrant Dermatoses (1998) (1)
Proton pump inhibitor‐induced subacute cutaneous lupus erythematosus (2022) (1)
Introducing Misha Rosenbach, MD, section editor for JAMA Dermatology patient page. (2013) (1)
Association of Cicatricial Pemphigoid and Rheumatoid Arthritis (1979) (1)
Self-Healing Congenital Langerhans Cell Histiocytosis Presenting as Neonatal Papulovesicular Eruption (2001) (1)
On the Horizon: Test to Predict Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (2011) (1)
A pregnancy-prevention program in women of childbearing age receiving isotretinoin: Mitchell AA, vanBennekon CM, Louik C. N Engl J Med 1995;333:101–106 (1995) (1)
Multiple drugs as inducing or exacerbating agents in subacute cutaneous lupus erythematosus (2020) (1)
Ioversol-Induced Acute Generalized Exanthematous Pustulosis (2016) (1)
Dermatomyositis: current controversies 1987. (1988) (1)
A new look for JAMA Dermatology (2013) (1)
Henoch Schönlein Purpura — Observations from a Large Cohort in Northwest Spain (2014) (0)
Should We Routinely Prescribe Folic Acid Supplementation for Methotrexate Recipients (2009) (0)
Increased Anti-Annexin 1 Antibodies Are Likely in Discoid Lupus Erythematosus (2011) (0)
Pruritus and the Risk for Malignancy (2014) (0)
Are TNF Antagonists Beneficial for Cardiovascular Disease (2014) (0)
Does Anti–Tumor Necrosis Factor α Therapy Increase the Risk for Serious Infection? (2011) (0)
Omalizumab Effective for Chronic Urticaria (2011) (0)
Azathioprine Might Be Effective for Intractable Pruritus (2015) (0)
Adalimumab a “Proven” Therapy for Hidradenitis Suppurativa (2012) (0)
Does Amyopathic Dermatomyositis Exist? Is It Associated with Malignancy? (2002) (0)
Autoantibodies Produced by Castleman Tumors in Patients with Paraneoplastic Pemphigus (2004) (0)
Intravenous Immune Globulin: A New Treatment for Livedoid Vasculitis (2004) (0)
PDE-5 Inhibitors for Treatment of Raynaud Phenomenon (2014) (0)
13786 Capillaritis which on DIF revealed IgA vasculitis (2020) (0)
Histoplasmosis and Anti-TNF-α Therapies -- Reason for Pause? (2002) (0)
Paraneoplastic Syndromes for the Inpatient Dermatologist (2019) (0)
Nonbullous Neutrophilic Lupus Erythematosus – The Real Deal or a Variant of Neutrophilic Dermatosis? (2012) (0)
Low Hydroxychloroquine Concentration Predicts Lupus Erythematosus Exacerbation (2006) (0)
Combination Antimalarials Improve Cutaneous Dermatomyositis in Some (2005) (0)
Biologic Agents for Erythrodermic Psoriasis (2012) (0)
Publication as online first (2011) (0)
Autoantibody Formation Precedes Development of Systemic Lupus Erythematosus (2003) (0)
IVIG for Livedoid Vasculopathy: Effective but Expensive (2014) (0)
Paraneoplastic Cutaneous Vasculitis — Incidence and Predictive Features (2013) (0)
Depressing News Relating to Oral Isotretinoin (2010) (0)
Beyond Skin and Joints: Psoriasis and the Metabolic Syndrome (2007) (0)
Gross and m icroscopic s Vmpos|um The spectrum of Reiter's (1979) (0)
Associated Skin Disease Years After Initiation of TNF Antagonists for Inflammatory Bowel Disease (2016) (0)
Another Smoking Gun: The Effects of Cigarettes on Skin Aging (2008) (0)
Livedoid Vasculopathy in Chinese Patients — What's Different? (2014) (0)
Aspirin May Prevent Melanoma in Postmenopausal Caucasian Women (2013) (0)
Unraveling the Genetic Predisposition to Systemic Lupus Erythematosus (2008) (0)
Why You Should Know About Statistics (2007) (0)
Problems of Abuse and Misuse of Laboratory Testing (1980) (0)
Severe Psoriasis Increases Risk for Cardiovascular Disease (2011) (0)
Facial Wrinkling and Chronic Lung Disease — The Susceptibilities Are Linked! (2006) (0)
Molecular Genetic Classification Is Useful in Patients with Polyposis (2006) (0)
High Serum IFN-α Is a Heritable Risk Factor for Systemic Lupus Erythematosus (2007) (0)
Curettage and Electrodesiccation of Low-Risk SCCs Apparently Effective in Organ Transplant Recipients (2006) (0)
Simvastatin/Ezetimibe, a Lipid-Lowering Combination Pill, Might Be Effective for Alopecia Areata (2015) (0)
Unusual Radiologic Shadows Due to Calamine Lotion (1984) (0)
Epidemiology of Polymorphic Eruption of Pregnancy (2008) (0)
Commercial Ear Piercing More Risky in Cartilage Than in the Earlobe (2004) (0)
Should We Put Statins in the Water? A Possible Therapy to Speed Healing of Venous Ulcers (2014) (0)
A new day for "On the Horizon". (2005) (0)
Our Appreciation to Our Reviewers (2003) (0)
Now, Another Reason to Advise Patients Not to Smoke (2007) (0)
Pulmonary Disease in Dermatomyositis and Its Treatment (2010) (0)
Scleromyxedema-like Changes in Dialysis (2003) (0)
The N-of-1 Trial: Implications for Biologic Therapies in Psoriasis (2008) (0)
Lymphomatoid Papulosis in Children Is Not Always Benign (2004) (0)
Relationship between porphyria cutanea tarda (PCT) and viral hepatitis: Tsukazaki N, Tanaka K, Irifune H, et al., J Dermatol 1994;21:411-4 (1995) (0)
How Can We Diagnose and Treat Mucous Membrane Pemphigoid (2002) (0)
Primary Cutaneous Vasculitis (Small Vessel Vasculitis) (2012) (0)
Sarcoidosis in Patients with Hepatitis C Comes in Two Flavors (2005) (0)
Off-Label Uses of Biologic Agents — A Systematic Review (2008) (0)
Ustekinumab for Chronic Plaque Psoriasis (2008) (0)
Itraconazole Promising for Palmoplantar Pustulosis (2009) (0)
Don't Eat That Gluten! (2003) (0)
Do m-TOR Inhibitors Cause Bullous Pemphigoid? (2014) (0)
Squamous Cell Carcinoma Complicates Hidradenitis Suppurativa (2010) (0)
Symmetric polyarthritis as the presenting manifestation of scleromyxedema (1996) (0)
Survival of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrosis (2013) (0)
Cardiovascular Diseases and the Skin (2009) (0)
HIT May Increase Risk for Warfarin-Induced Necrosis (2004) (0)
Sweet's Syndrome (2017) (0)
What Is Clinically Amyopathic Dermatomyositis (2006) (0)
Elevated cancer incidence in patients with dermatomyositis: a population-based study: Airio A, Pakkala E, Isomāki H. J Rheumatol 1995; 22:1300–1303 (1995) (0)
Mycophenolate Mofetil for Pemphigus (2003) (0)
Can Serologic Testing Aid in the Identification of Dermatomyositis-Associated Cancer? (2013) (0)
Dermatomyositis and malignancy: Commentary on a recent report and the need for increased scrutiny of reports of disease associations (1985) (0)
The Immunologic Profile Is “Permanently” Changed in Patients with Pemphigus and a Complete Response to Rituximab (2013) (0)
CK7 negative anaplastic thyroid carcinoma presenting as cutaneous metastases to the scalp. (2018) (0)
In Patients Reactive to Balsam of Peru and Fragrance Mix, Restricted Diet Helps (2001) (0)
Not an Indicator of Drug-Induced Subacute Cutaneous Lupus Erythematosus (2013) (0)
Nephrogenic Fibrosing Dermopathy Is a Systemic Disease (2006) (0)
THE VALUE OF METHOTREXATE IN DERMATOMYOSITIS. AUTHORS' REPLY (1998) (0)
Skin Biopsies Are Helpful for Identifying Infection in Patients with Leukemia (2014) (0)
Prognosis in Melanoma with Associated Dermatomyositis Depends on Stage (2006) (0)
Drug-Induced Cutaneous Vasculitis — A Recent Update (2014) (0)
Revised Clinical Slide Collection on the Rheumatic Diseases (1982) (0)
Phototherapy for Localized Scleroderma (2006) (0)
Isotretinoin and Inflammatory Bowel Disease (2009) (0)
Intralesional Rituximab for Recalcitrant Oral Ulcerations of Pemphigus Vulgaris (2015) (0)
When and How to Assess Patients with Dermatomyositis for Cancer (2002) (0)
Ultrapotent Topical Corticosteroids Are Effective for Erosive Lichen Planus of the Vulva (2006) (0)
New Treatment for Necrobiosis Lipoidica (2005) (0)
New Treatment for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis? (2014) (0)
Cutaneous photosensitivity in dermatomyositis: Cheong WK, Hughes GRV, Norris PG, et al. Br J Dermatol 1994;131:205–208 (1995) (0)
Treat Cutaneous Manifestations of Dermatomyositis — Improve Quality of Life (2014) (0)
Is Etanercept Associated with Drug-Induced Lupus Erythematosus? (2002) (0)
Another Inflammatory Disease Linked to Thrombosis (2013) (0)
Use of antibiotics and risk of cancer. Authors' reply (2004) (0)
Apremilast Might Be Effective for Pityriasis Rubra Pilaris (2015) (0)
26892 Secondary cutaneous follicular center lymphoma presenting after use of topical fluorouracil for actinic keratosis (2021) (0)
Muckle-Wells Syndrome — A Diagnosis Frequently Delayed (2014) (0)
The diaper rash that needed more than a little cream 1 1 Disclosure not available at press time. (2004) (0)
The skin, the eye, and systemic disease. (1979) (0)
Skin Signs of Systemic Diseases. (2021) (0)
Postoperative Pyoderma Gangrenosum (2015) (0)
The Significance of Discoid Lupus Erythematosus in Patients with Systemic LE (2013) (0)
Reclassification of Eruptions Associated With Pregnancy (2006) (0)
CD30+ Cutaneous Lymphoma Reported in Patients with Long-Standing Atopic Eczema (2004) (0)
The journal name: representing worldwide instant accessibility. (2012) (0)
Methotrexate with Pulsed Methylprednisolone Is Effective for Localized Scleroderma (2005) (0)
A Fond Farewell (2014) (0)
Anti–Melanoma Differentiation–Associated Gene 5 (MDA-5) Antibody and Dermatomyositis (2013) (0)
Vasculitis Associated with Malignancy (2008) (0)
Smoking Cutaneous Lupus Erythematosus Patients Have More Severe Disease, Lower Response to Antimalarials (2014) (0)
Internal Medicine: Keloids (2007) (0)
State of the Archives: Fulfilling Our Mission (2010) (0)
Dermatomyositis Patients with the MDA-5 Antibody Have Increased Pulmonary Disease and Skin Ulcerations (2012) (0)
Autologous Peripheral Stem-Cell Transplantation a Temporary Success for Scleromyxedema (2005) (0)
Apremilast May Be Useful in Patients with Discoid Lupus Erythematosus (2012) (0)
ANNUAL MEETING, SYDNEY, 1987 (1986) (0)
Are Henoch-Schönlein purpura and hypersensitivity vasculitis in adults truly distinct entities? A dermatologist's perspective. (2000) (0)
Biologic Therapy Apparently More Effective Than Oral Therapy for Glucocorticoid-Associated Osteoporosis (2007) (0)
Methotrexate May Be Effective for Cutaneous Lupus Erythematosus (2005) (0)
Oral Mucous Membranes and Systemic Disease (2009) (0)
Patients with Anetoderma Often Have Procoagulant Biomarkers (2003) (0)
Psoriasis Is Related to Weight Gain in Women (2007) (0)
Intravenous Immune Globulin Effective for Treating Cutaneous Dermatomyositis (2014) (0)
Cutaneous Leukocytoclastic Vasculitis: Usually a Benign Course (2006) (0)
Lymphangioma circumscriptum associated with elephantiasis lymphangiomatosa (1995) (0)
Lupus-Like Syndrome Caused by Tumor Necrosis Factor α Antagonists (2009) (0)
Tetracycline Antibiotics and Niacinamide as Steroid-Sparing Agents for Pemphigus (2014) (0)
Pink Papules and Papulovesicles from Organic Mercury, not Pink Disease (2003) (0)
Eruptive Xanthomas Associated with Olanzapine Therapy (2003) (0)
JAMA Dermatology-The Year in Review, 2015. (2016) (0)
Dermatitis Might Reflect a Systemic Autoinflammatory Syndrome (2013) (0)
Are Liver Biopsies Necessary in Psoriasis Patients Treated with Methotrexate (2007) (0)
Does Antimalarial Therapy Delay SLE Onset (2007) (0)
Long-Term Outcomes in Patients with Dermatomyositis and Polymyositis (2001) (0)
Emergencies in Patients with Hereditary Hemorrhagic Telangiectasia (2006) (0)
Rituximab for Management of Bullous Pemphigoid (2015) (0)
Bullous Pemphigoid and Malignancy — Isn't It Time That This Potential Association Be Retired from Our Thinking? (2015) (0)
Recognition and Diagnosis of Cellulitis Is Improved by Dermatologic Consultation in the Outpatient Setting (2014) (0)
JAMA Dermatology. (2016) (0)
Letter: Diagnosis of superior-vena-cave obstruction. (1974) (0)
Methotrexate Appears to Be a Steroid-Sparing Agent for Patients with Pemphigus (2014) (0)
Discordance Between Immune Deposits in Patients with IgA Cutaneous Vasculitis and IgA Nephropathy (2014) (0)
Cutaneous Toxicity Associated with “New” Therapies: Rare but Possible (2009) (0)
Rituximab Is Not Effective for Chronic or Subacute Cutaneous Lupus Erythematosus (2015) (0)
Cutaneous dermatomyositis in the era of biologicals (2015) (0)
New Warning Issued for Rituximab (2006) (0)
Rituximab Therapy for ANCA-Associated Vasculitis (2010) (0)
New Class of Drugs Linked to Cutaneous Lupus (2004) (0)
Risk for Nonmelanoma Skin Cancer Appears Higher in Tumor Necrosis Factor Antagonist Recipients (2011) (0)
Resident rounds. Part III. Erosive and desquamative syphilis associated with mucositis in the setting of acquired immune deficiency syndrome. (2011) (0)
Antihistone Antibodies: Not as Useful as Hoped (2004) (0)
Nephrogenic Fibrosing Dermopathy -- First Reports (2003) (0)
Psychiatric implications of psoriasis. Authors' reply (2006) (0)
Aquagenic Pruritus and Polycythemia Vera (2013) (0)
Rare cutaneous manifestation of prostate cancer. (2010) (0)
Autoantibodies to Type VII Collagen May Precede the Development of Bullous Lupus Erythematosus (2015) (0)
Counting Hairs: Is It Androgenetic Alopecia or Chronic Telogen Effluvium? (2005) (0)
Do Anti-TNF Agents Increase Risks for Malignancy and Infection? (2004) (0)
Another IL-23 Antagonist Appears to Be Effective for Management of Psoriasis (2015) (0)
Investigating Clofazimine for LE Lesions (2005) (0)
Antiphospholipid Antibodies in Patients with Small-Vessel Vasculitis (2008) (0)
Subclinical Cardiovascular Disease Is Frequent in Patients with Severe Psoriasis (2012) (0)
Rituximab of Little Help for Patients with Relapsing Polychondritis (2009) (0)
Can We Safely and Effectively Immunize Patients Receiving Anti-TNF Therapies? (2007) (0)
Calcinosis cutis: an additional therapy to consider. (2012) (0)
A Raised Risk for NMSC in Patients with Inflammatory Bowel Disease (2012) (0)
Minocycline-Induced Hyperpigmentation Masquerading as Alkaptonuria (2004) (0)
Newly Uncovered Aspects of Drug-Induced Hypersensitivity Syndrome (2009) (0)
New Information on Juvenile Polyarteritis Nodosa (2005) (0)
Pyoderma Gangrenosum: Perhaps a Poorer Prognosis When Patient Has Arthritis (2004) (0)
Flushing Is Not the Only Skin Sign of Carcinoid Tumors (2005) (0)
Nonmelanoma Skin Cancer (NMSC) and Tumor Necrosis Factor Antagonists — Increased Risk or Not? (2005) (0)
Skin signs of systemic disease (2002) (0)
Etanercept May Be Effective for Hidradenitis Suppurativa (2006) (0)
The editorial board leads the way (2008) (0)
Patients Taking Disease-Modifying Antirheumatic Drugs Also Developed Less New Diabetes (2011) (0)
Rheumatoid Vasculitis Has Many Clinical Manifestations (2002) (0)
Maintenance Therapy for ANCA-Associated Vasculitis — Azathioprine or Methotrexate? (2008) (0)
Secukinumab for Psoriatic Arthritis (2015) (0)
Dermatologic Manifestations of Internal Malignancy (2011) (0)
Psychiatric Implications of Psoriasis—Reply (2006) (0)
Radon and Skin Cancer — Yet Another Risk Factor for Squamous Cell Carcinoma? (2012) (0)
Are Tumor Necrosis Factor Antagonists Safe in Pregnancy (2009) (0)
The Biggest Losers Win (2009) (0)
LB939 Pruritic and dyskeratotic dermatosis: An unusual cutaneous manifestation (2020) (0)
Pyoderma Gangrenosum Is a Diagnosis of Exclusion (2002) (0)
Internal involvement in localized scleroderma (1995) (0)
The HORIZON Study: Bisphosphonates for Patients on Corticosteroids (2009) (0)
Biologics and Methotrexate Lower Rates of Cardiovascular Death, Myocardial Infarction, and Stroke in Patients with Severe Psoriasis (2012) (0)
086 Familial Tree of Epidermolytic Ichthyosis Suggesting a Novel Genetic Mutation (2021) (0)
Can Pemphigus Vulgaris Be Treated with a Subcutaneous Injection (2014) (0)
New Treatments for Lichen Planopilaris (2010) (0)
Mycophenolate Sodium Is Effective for Subacute Cutaneous LE (2007) (0)
Do Calcium Channel Blockers Cause Chronic Eczema in Elderly Adults (2007) (0)
No Hard-Bound Rules for Defining the Lipodermatosclerosis Patient (2002) (0)
A New Medicine for Psoriatic Arthritis (2014) (0)
Herpes Zoster and Treatments for Psoriasis (2015) (0)
Sleep Apnea — Another Risk Factor for the Development of Psoriasis? (2012) (0)
Comparing Three Drug Regimens for Juvenile Dermatomyositis (2015) (0)
Malignancy Is (Still) Associated with Dermatomyositis (2010) (0)
Methotrexate and Cyclosporine Equally Effective for Chronic Plaque Psoriasis (2003) (0)
Erectile Dysfunction Appears to Be More Prevalent in Psoriatic Patients (2012) (0)
Sweet Syndrome — New Insights? (2013) (0)
Generalized linear IgA dermatosis with palmar involvement - eScholarship (2015) (0)
Should Hydroxychloroquine Be Discontinued During Pregnancy (2006) (0)
Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis (2007) (0)
Acquired unilateral nevoid telangiectasia in pregnancy (2018) (0)
IL-17 Targeting Appears to Be Effective for Psoriasis Patients (2012) (0)
Etanercept for Juvenile Dermatomyositis: Not Yet Ready for Adoption (2014) (0)
CDC Report on Gadolinium-Associated Nephrogenic Fibrosing Dermopathy (2007) (0)
The “True” Heartbreak of Psoriasis — Undertreatment or No Treatment (2013) (0)
31911 Postsurgical atypical mycobacterial infection misdiagnosed as pyoderma gangrenosum (2022) (0)
Erythema Nodosum and Pyoderma Gangrenosum in Inflammatory Bowel Disease (2008) (0)
AESOP -- A New Syndrome (2003) (0)
Statistics: Producing Unreliable Facts from Reliable Figures? (2010) (0)
Livedo Reticularis Is an Independent Risk Factor for Fetal Loss (2005) (0)
Smoking Is Associated with Increased Risk for Nonmelanoma Skin Cancer (2012) (0)
Mycophenolate Mofetil Is Effective as a Steroid-Sparing Agent for Pyoderma Gangrenosum (2013) (0)
Polymorphic Eruption of Pregnancy (2006) (0)
Intravenous Immunoglobulin in the Treatment of Pemphigus (2009) (0)
Is Bullous Pemphigoid Associated with Neurologic Disorders (2014) (0)
Management of Patients with Coexistent Psoriasis and Lupus Erythematosus (2015) (0)
Prevalence of Cutaneous Adverse Events Associated with TNF-α Therapy for Rheumatic Diseases (2014) (0)
Acetaminophen Receives a Labeling Change — Is Anything Safe? (2013) (0)
Delayed Diagnosis Means Poorer Prognosis in Juvenile Dermatomyositis (2006) (0)
Risk Factors for Death in Patients with Bullous Pemphigoid (2002) (0)
Farewell to skINsight: Comment on “Rorschach Dermoscopy” (2012) (0)
Thalidomide Was Ineffective for Cutaneous Sarcoidosis (2014) (0)
Papular Sarcoidosis of the Knees: Acute, Self-Resolving, and a Good Prognosis (2003) (0)
Features of Paraneoplastic Pemphigus (2004) (0)
Xanthelasma, but Not Arcus Senilis, Predicts Atherosclerotic Vascular Disease and Death (2011) (0)
A Possible Viral Cause of DRESS (2014) (0)
The Safety of Mycophenolate Mofetil for Dermatomyositis (2006) (0)
Measuring Hydroxychloroquine Blood Levels Improves Adherence (2016) (0)
Methotrexate, With or Without Corticosteroids, Might Benefit Sclerosing Skin Disease (2009) (0)
Ultraviolet Hardening for Patients with Cutaneous Lesions of Lupus Erythematosus (2006) (0)
Henoch-Schönlein Purpura Is Linked to HLA-DRB Genetic Aberrations (2015) (0)
New Therapy for Neonatal-Onset Multisystem Inflammatory Disease (2006) (0)
Antinuclear and Anti-dsDNA Antibodies Might Predict Anti–TNF-α Treatment Failure (2010) (0)
Book Review Rook/Wilkinson/Ebling Textbook of Dermatology Sixth edition. Edited by R.H. Champion, J.L. Burton, D.A. Burns, and S.M. Breathnach. 3683 pp. in four volumes, illustrated. Boston, Blackwell Science, 1998. $695. 0-632-03796-2 (1999) (0)
Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene): Waller PA, Clauw D, Cupps T, et al. J Rheumatol 1994;21:1567-70 (1995) (0)
OBSERVATION Development of Sarcoidosis in Cosmetic Tattoos (2005) (0)
Methotrexate for Alopecia Areata (2015) (0)
Psoriasis and Co-Morbid Disease: A Dose Response in Relation to Psoriasis Severity (2013) (0)
Blood Levels Might Predict Response to and Compliance with Therapy in Patients with CLE (2012) (0)
Topical Tacrolimus: Adjunctive Therapy for Cutaneous Lupus Erythematosus? (2004) (0)
Germline mutation in ATR underlying a new autosomal dominant oropharyngeal cancer syndrome (2012) (0)
STING-Associated Vascular and Pulmonary Syndrome (2015) (0)
Cross-Reactions to Antiepileptic Drugs Are Common (2008) (0)
Mycophenolate Mofetil May Be Effective for Chronic Urticaria (2011) (0)
Erratum: American Academy of Dermatology Consensus Conference on the Safe and Optional Use of Isotredtinoin: Summary and recommendations (Journal of the American Academy of Dermatology (June 2004) 51 (900-906)) (2004) (0)
JAMA Dermatology-The Year in Review, 2016. (2017) (0)
Paraneoplastic Acral Vascular Syndrome (2002) (0)
Statins Might Benefit Digital Ulcerations and Raynaud Phenomenon (2008) (0)
Can We Safely and Effectively Vaccinate Patients Receiving Biologic Therapies for Immune-Mediated Disease? (2012) (0)
Anakinra Might Be Effective for the Management of Hidradenitis Suppurativa (2015) (0)
Genetic linkage of a new autosomal dominant poikiloderma-upper oesophageal cancer syndrome to a 21-cM interval on 3q21-24 (2009) (0)
Psoriatic Arthritis in Patients Treated with Efalizumab (2008) (0)
Current and future treatment options for cutaneous lupus erythematosus (2015) (0)
A “New” Treatment for Lipodermatosclerosis? (2012) (0)
About your medicines. U.S. Pharmacopeial Convention, Inc., Rockville, MD (March, 1981), Complete reference edition, 594 pages, $8.95. Consumer abridged edition, 398 pages, $4.50. (1981) (0)
Rituximab Might Be Useful for Recalcitrant Subacute Cutaneous Lupus Erythematosus (2012) (0)
Severe Drug Reactions with Eosinophilia and Systemic Symptoms: A Herpesvirus Connection? (2009) (0)
Acral psoriasiform eruption in a man with squamous cell carcinoma of the tonsillar pillar. (2005) (0)
Childhood Dermatomyositis and Increased Cardiovascular Disease Risk Factors in Adulthood (2012) (0)
Urticarial Vasculitis: Clinical Study of a Rare Entity (2014) (0)
Disseminated Kaposi’s Sarcoma in a Patient With Acquired Ichthyosis (1984) (0)
A Previously Undescribed Manifestation of Sclerosing Mesenteritis (2017) (0)
Misoprostol Effective in Management of Erythromelalgia (2004) (0)
Neonatal Lupus Erythematosus (2000) (0)
Biomarkers in Rheumatic Diseases with Cutaneous Manifestations (2016) (0)
The Biologic Age Is Upon Us -- In Full Swing! (2003) (0)
Drug-Induced Dermatomyositis Due to Tumor Necrosis Factor Antagonists (2010) (0)
Patients with Atrophie Blanche May Have Serious Underlying Vasculitis (2003) (0)
Paraneoplastic Pemphigus and Castleman Tumor (2005) (0)
Lower-Cost Combination Therapies Were Not Inferior to Biologics for Rheumatoid Arthritis (2013) (0)
Treatment of Pyoderma Gangrenosum — Is Prednisolone or Cyclosporine Best? (2015) (0)
Use of antibiotics and risk of cancer [1] (multiple letters) (2004) (0)
Small Vessel Vasculitis: A Complication of Tumor Necrosis Factor-α Blocking Agents (2004) (0)
Dermatomyositis Skin Disease Affects Quality of Life (2012) (0)
Calcium-Channel Blockers and Chronic Eczematous Eruptions of the Aged (2013) (0)
Lipodystrophy in a Type 1 Diabetic Woman (2018) (0)
Urticarial Dermatitis: When to Diagnose? (2014) (0)
Oral Retinoids Reduce Risk for PUVA-Associated SCC (2003) (0)
Infection Usually Involves the Skin and Is Frequently Fatal (2013) (0)
Asthma Appears to Be a Risk Factor for Herpes Zoster (2016) (0)
Proceedings of the Second Update on Psoriatic Disease, University Federico II Congress Center, July 6–7, 2011, Naples, Italy. (2012) (0)
The Impact of Vasculitis in Systemic Lupus Erythematosus (2006) (0)
JAMA Dermatology. (2018) (0)
Chronic, Relapsing, Debilitating Sweet Syndrome Is Associated with Myelodysplasia (2015) (0)
Less Than an Ounce of Prevention: Condoms Protect Against HSV-2 (2006) (0)
Xanthomas heralding pediatric coronary artery disease (2020) (0)
JAMA Dermatology. (2017) (0)
Chronic Voriconazole Use and SCCs (2010) (0)
Alitretinoin Is Effective for Cutaneous Lupus Erythematosus (2012) (0)
Increased Autoimmune Disease Found in Families of Children with Juvenile Dermatomyositis (2011) (0)
Manual of dermatology : introduction to diagnosis and treatment (1980) (0)
Localized Scleroderma in Children is Effectively Managed with Methotrexate (2006) (0)
Alefacept Is Effective for Psoriasis (2002) (0)
Methemoglobinemia as a Complication of Topical Dapsone Therapy (2015) (0)
Combination Biologic Therapy for Recalcitrant Pemphigus Vulgaris (2006) (0)
Mycophenolate Mofetil Is Inferior to Azathioprine for Maintaining Remission in ANCA-Associated Vasculitides (2010) (0)
Topical Phenytoin — A New Therapy for Pyoderma Gangrenosum? (2010) (0)
Porphyria cutanea tarda remission (1995) (0)
Infliximab Is the Most Effective Treatment for Lupus Pernio (2008) (0)
Allopurinol — Severe Drug Reactions and Potential Death Are More Frequent Among Users than Nonusers (2013) (0)
Principles of Treatment of Cutaneous Drug Eruptions (2015) (0)
Is Hydroxychloroquine Safe to Use During Pregnancy (2003) (0)
Creatine Supplementation May Help Inflammatory Myopathy-Related Weakness (2007) (0)
Omalizumab Is Potentially Useful for Bullous Pemphigoid (2014) (0)
Support for Aggressive Early Treatment of Childhood Dermatomyositis (2002) (0)
Hydroxychloroquine Treatment for Discoid Lupus Erythematosus (2011) (0)
Some Patients with Cutaneous Sarcoidosis Benefit from Thalidomide (2004) (0)
A New Calcineurin Inhibitor Is Effective for Psoriasis Vulgaris (2008) (0)
Which New Medications May Cause SJS or TEN (2008) (0)
Multiple flesh-colored nodules on the chin following trauma1 (2004) (0)
Development of Anti-Adalimumab Antibodies Linked to Decreased Treatment Effect (2011) (0)
Biologic Therapies Appear to Increase Skin Cancer Risk in Rheumatoid Arthritis Patients (2007) (0)
Development of Antirituximab Antibodies May Portend Therapy Failure in Patients with Pemphigus (2009) (0)
Relationship of Bowen's and Non-Bowen's Squamous Intraepidermal Neoplasia to Internal Malignant Neoplasms-Reply (1981) (0)
Childhood Polyarteritis Nodosa (2013) (0)
Ustekinumab Appears to Be Effective Against Psoriatic Arthritis (2009) (0)
Predicting Prognosis for Scleroderma Patients (2002) (0)
Infliximab Is Effective for Pyoderma Gangrenosum with or without Inflammatory Bowel Disease (2006) (0)
Apremilast — an Oral Agent — Is Effective for Plaque Psoriasis (2012) (0)
Lymphomatoid Papulosis -- Clarity or More Confusion? (2004) (0)
Another Biologic Proves Superior to Methotrexate (2011) (0)
Two New Treatments for Schnitzler Syndrome (2012) (0)
Anakinra — Perhaps, a New Therapy for Pyoderma Gangrenosum? (2009) (0)
Excess Androgens in Women with Acne -- With or Without Hirsutism (2001) (0)
Squamous cell carcinoma of the skin. (1980) (0)
Newly Approved Dermatologic Drugs (2014) (0)
Women on HRT are Less Likely to Develop Skin Ulcers (2002) (0)
Schnitzler Syndrome Is Effectively Managed with Long-Term Administration of Anakinra (2015) (0)
Remember to Consider Malignancy in Patients with Chronic, Nonhealing Wounds (2013) (0)
Paraneoplastic, Inherited Cancer Syndrome, and Environmental Carcinogen‐Related Dermatoses (2013) (0)
Endometriosis History Linked to Increased Melanoma Risk (2007) (0)
Yellow Nail Syndrome Might Respond to Vitamin E Therapy (2014) (0)
Is IVIg Effective for Toxic Epidermal Necrolysis in Children (2002) (0)
Etanercept Is Effective for Sarcoidosis -- Or Is It? (2003) (0)
Reticular Erythematous Mucinosis — What Exactly Is This Condition? (2013) (0)
Is Cutaneous Small-Vessel Vasculitis a Marker of Internal Malignancy? (2011) (0)
Oral Cyclophosphamide for Pemphigus (2003) (0)
25656 Vulvar discoid lupus erythematosus: An unusual site for cutaneous lupus erythematosus (2021) (0)
Will a Biologic Agent Be Useful for Managing Lupus-Associated Skin Disease? (2010) (0)
Antimalarial Therapy Protects Patients with Lupus Erythematosus Against Thrombovascular Disease (2010) (0)
Another Reason to Tell Patients with Cutaneous Lupus Erythematosus to Quit Smoking (2012) (0)
Another Myositis-Specific Antibody: Is It Linked to Malignancy? (2012) (0)
Isotretinoin Does Not Appear to Increase Acute Risk for Thromboembolic Disease (2011) (0)
Double Benefit: Alopecia Universalis and Psoriasis Respond to Tofacitinib (2015) (0)
Omalizumab Effectively Controls Chronic Idiopathic or Spontaneous Urticaria (2013) (0)
Does Paternal Exposure to Methotrexate Affect Birth Outcomes (2011) (0)
What Is the Best Adjunctive Therapy for Pemphigus (2007) (0)
Etanercept Alleviates Fatigue and Depression Along with Psoriasis (2006) (0)
Rituximab for Juvenile Dermatomyositis (2011) (0)
Thank You to Our Reviewers (1998) (0)
Case report Generalized linear IgA dermatosis with palmar involvement (2015) (0)
New Manifestations of the Neonatal Lupus Erythematosus Syndrome (2007) (0)
Mycophenolate Mofetil Is Useful for Antimalarial-Resistant Cutaneous Lupus Erythematosus (2011) (0)
A New Medical Treatment for Calciphylaxis (2006) (0)
Folic Acid May Prevent Nonmelanoma Skin Cancer in Renal Transplant Recipients (2007) (0)
Another Oral Agent Demonstrates Clinical Improvement in Chronic Plaque Psoriasis (2014) (0)
Reticular Erythematous Mucinosis and Lupus Erythematosus Tumidus — Different Diseases or Variations on a Theme? (2014) (0)
A 10-year retrospective on Advances in Dermatology. (1995) (0)
Cutaneous Manifestations in Patients with Antiphospholipid Syndrome (2002) (0)
Schnitzler Syndrome Might Be More Prevalent Than We Thought (2014) (0)
Our Thanks to Peer Reviewers in 2012 (2012) (0)
Cutaneous Lesions of Azathioprine Hypersensitivity Syndrome (2011) (0)
Highlights from the university of louisville’s clinicopathologic conference (2004) (0)
Potential Association Between Tetracycline Antibiotics and Inflammatory Bowel Disease (2010) (0)
Smoking, Severity of Cutaneous Lupus Erythematosus, and Response to Therapy — What's the Right Answer? (2011) (0)
Acknowledgment of 2009 Reviewers (2010) (0)
IVIG and TEN: What Are We to Believe, and How Should We Manage Our Next Patient? (2012) (0)
Smoking Interferes with Antimalarial Therapy (2015) (0)
Introducing the Clinical Evidence Synopsis Section (2015) (0)
Psoriasis Patients Treated with Cyclosporine Have Higher Risk for Nonmelanoma Skin Cancer (2003) (0)
Nephrogenic fibrosing dermopathy following acute renal failure in a patient never treated with dialysis 1 1 Disclosure not available at press time. (2004) (0)
Erythema Nodosum and Other Panniculitides (2009) (0)
Less Common Arthropathies (2008) (0)
Will Guselkumab Raise the Bar for Judging Response in Future Studies of Psoriasis (2015) (0)
Schnitzler Syndrome: A Review of 20 Patients (2012) (0)
Patients with Psoriasis Have an Increased Risk for Coronary Artery Disease (2012) (0)
Evaluation and Management of Complex Aphthosis (2005) (0)
Cutaneous Neonatal Lupus Erythematosus and Risk for Heart Block in Subsequent Pregnancy (2010) (0)
The association of two antimalarials, chloroquine and quinacrine, for treatment-resistant chronic and subacute cutaneous lupus erythematosus (1995) (0)
What Does Presence of Discoid Lupus Erythematosus in Patients with Systemic Lupus Erythematosus Imply for Prognosis (2015) (0)
Discoid Lupus Erythematosus in Children (2003) (0)
Azathioprine for Atopic Dermatitis — Dosing by Thiopurine Methyltransferase Activity (2006) (0)
Tofacitinib Might Be Effective for Severe, Recalcitrant Atopic Dermatitis (2015) (0)
Calciphylaxis -- Recent Reports on Managing This Life-Threatening Dermatosis (2002) (0)
Desensitization Allows Restart of Hydroxychloroquine in Patients with Previous Drug Eruptions (2006) (0)
WS086 Recent review of the internal medicine literature (1997) (0)
Antimalarial Agents Are Effective for Reticular Erythematous Mucinosis (2011) (0)
Is There an Association Between Minocycline and Autoimmune Disease (2007) (0)
Lymphomatoid papulosis and progression to T‐cell immunoblastic lymphoma (1998) (0)
Is There an Effective Therapy for Uremic Pruritus Associated with Dialysis (2006) (0)
Expert Commentary on the Management of Peristomal Pyoderma Gangrenosum in a Patient With IBD. (2020) (0)
Limitations of Direct Immunofluorescence-Reply (1992) (0)
Prevention of severe acute sunburn in patients receiving phototherapy (1995) (0)
Skin signs of systemic disease: A set of 10 cases (1996) (0)
What Is the Best Therapy for Merkel Cell Carcinoma (2004) (0)
Renal Involvement is Frequent in Patients with Cutaneous Small-Vessel Vasculitis in Crete (2002) (0)
Is “Drug-Induced” Linear IgA Bullous Dermatosis a Separate Entity? (2012) (0)
Taking the ER out of dERm (2010) (0)
Acitretin for Preventing BRAF Inhibitor Therapy–Related Complications in Advanced Melanoma (2013) (0)
Condoms Prevent Herpes Simplex Virus Type 2 (2009) (0)
Bosentan -- A New Oral Therapy for Severe Raynaud Phenomenon (2005) (0)
New Treatment for Hepatitis C Viral Infection Is Effective for Associated Porphyria Cutanea Tarda (2015) (0)
Do Squamous Cell Carcinomas Develop More Rapidly in Patients Treated with Etanercept (2011) (0)
Which Therapy, and How Aggressive, for Ocular Pemphigoid? (2007) (0)
Hydroxychloroquine Blood Levels May Be Helpful in Patients with “Antimalarial-Resistant” Cutaneous Lupus Erythematosus (2016) (0)
How Safe Is Long-Term Hydroxychloroquine? (2014) (0)
Update on Risk for Infection and Malignancy with Anti-TNF Antibody Therapy (2006) (0)
Is Ustekinumab Effective for Palmoplantar Pustular Psoriasis (2013) (0)
Are Patients Who Use Sunscreens at Risk for Melanoma (2003) (0)
The Practice of Dermatology (1986) (0)
Acknowledgment of 2010 Reviewers (2011) (0)
Ustekinumab for Psoriatic Arthritis — A Viable Option? (2013) (0)
The diaper rash that needed more than a little cream1 (2004) (0)
Erythromelalgia -- Cutaneous Pain Syndrome or Vascular Abnormality? (2003) (0)
Development of Hyperlipidemia During Isotretinoin Therapy Indicates Future Risk (2002) (0)
How Many Patients with Antiphospholipid Antibodies Develop Lupus Erythematosus (2005) (0)
Restricted Cyclophosphamide Effective for Scleroderma Lung Disease, but at a Cost (2006) (0)
Pruritic urticarial papules pregnancy (PUPPP) (1981) (0)
Histopathology in erythroderma: review of a series of cases by multiple observers: Walsh NMG, Prokopetz R, Tron VA, et al. J Cutan Pathol 1994;24:419–423 (1995) (0)
Eruptions in Patients Treated with TNF-α Antagonists (2007) (0)
UV Light on the Earth's Surface Affects Inflammatory Myopathy (2003) (0)
Is Generalized Bullous Fixed Drug Eruption Different from Stevens-Johnson Syndrome? (2013) (0)
Farewell to the evidence-based dermatology section. (2014) (0)
Prolonged use of methotrexate for sarcoidosis (1995) (0)
Laboratory Tests in Patients with Chronic Urticaria (2003) (0)
Rubor, Dolor, Tumor, and Calor Do Not Always Equal Cellulitis (2015) (0)
Antineutrophil Cytoplasmic Antibodies — Clinically Useful Information from a Review (2006) (0)
Does Intramuscular Triamcinolone Result in Adrenal Suppression (2013) (0)
Osteoporosis: Another Risk for Patients with Psoriasis? (2009) (0)
Isotretinoin and Inflammatory Bowel Disease Revisited (2010) (0)
34065 Lupus panniculitis with facial hemiatrophy (2022) (0)
Canakinumab Might Be Effective for Pyoderma Gangrenosum (2015) (0)
Thalidomide Treatment of Cutaneous Lupus Erythematosus (2012) (0)
Psoriasis and the Risk for Major Cardiovascular Events (2015) (0)
Patients with Psoriasis Have a Slightly Increased Risk for Lymphoma (2003) (0)
Pruritus Alone or in Conjunction with Nonbullous Skin Lesions Might Still Represent Bullous Pemphigoid (2013) (0)
Alternate “Low” Dosing of Rituximab for Pemphigus May Be Effective (2012) (0)
Cryofibrinogenemia — What Is Its Clinical Significance? (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jeffrey P. Callen?

Jeffrey P. Callen is affiliated with the following schools:

University of Louisville